|

SN301A Clinical Trials

1 actively recruiting trial

Also known as: Cyclophosphamide, Fludarabine

Pipeline

Early 1: 1

Top Sponsors

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

  • Liver Disease1
  • Hepatocellular Carcinoma (HCC)1
  • Liver Cancer1
  • Cancer1

Other1 trial

Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.